Skip to main content
Premium Trial:

Request an Annual Quote

UCSD and TCAG Announce Pharmacogenomic Collaboration

NEW YORK, Sept. 26 (GenomeWeb News) - The University of California, San Diego and the Center for the Advancement of Genomics announced yesterday that they will be formally collaborating to use large-scale genome analysis to predict the occurrence and outcome of disease, with an initial focus on hypertension and cardiovascular disease.


In the hypertension study, UCSD will obtain DNA from a group of patients, then send it to TCAG for sequencing and SNP analysis. While TCAG conducts the sequencing, UCSD researchers will simultaneously run phenotyping tests.


UCSD actually began the hypertension study two years ago with a $2.9 million, four-year grant from the National Heart, Lung and Blood Institute as part of the NIH Pharmacogenomics network. Preliminary results will be announced next month at the Society for Human Genetics meeting in San Francisco.


UCSD's agreement with TCAG is detailed in a multi-year Memorandum of Understanding


The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.